124 related articles for article (PubMed ID: 21918190)
61. Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification.
Ghigo E; Capo C; Aurouze M; Tung CH; Gorvel JP; Raoult D; Mege JL
Infect Immun; 2002 Mar; 70(3):1501-6. PubMed ID: 11854238
[TBL] [Abstract][Full Text] [Related]
62. Whipple's disease: morphologic and immunofluorescence characterization of bacterial antigens.
Bhagavan BS; Hofkin GA; Cochran BA
Hum Pathol; 1981 Oct; 12(10):930-6. PubMed ID: 6170567
[TBL] [Abstract][Full Text] [Related]
63. Whipple's disease: a histological, immunocytochemical and electronmicroscopic study of the immune response in the small intestinal mucosa.
Ectors N; Geboes K; De Vos R; Heidbuchel H; Rutgeerts P; Desmet V; Vantrappen G
Histopathology; 1992 Jul; 21(1):1-12. PubMed ID: 1378814
[TBL] [Abstract][Full Text] [Related]
64. An immunoproteomic approach for identification of clinical biomarkers of Whipple's disease.
Kowalczewska M; Fenollar F; Villard C; Azza S; Roux M; Raoult D
Proteomics Clin Appl; 2008 Apr; 2(4):504-16. PubMed ID: 21136854
[TBL] [Abstract][Full Text] [Related]
65. Impaired intracellular pathogen clearance and inflammatory joint disease: Is Whipple's disease a guiding light?
Berthelot JM; Puéchal X
Joint Bone Spine; 2018 Oct; 85(5):531-536. PubMed ID: 28965939
[TBL] [Abstract][Full Text] [Related]
66. Whipple's disease.
Puéchal X
Postgrad Med J; 2013 Nov; 89(1057):659-65. PubMed ID: 24129033
[TBL] [Abstract][Full Text] [Related]
67. A patient with cerebral Whipple disease with gastric involvement but no gastrointestinal symptoms: a consequence of local protective immunity?
Prüss H; Katchanov J; Zschenderlein R; Loddenkemper C; Schneider T; Moos V
J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):896-8. PubMed ID: 17371903
[TBL] [Abstract][Full Text] [Related]
68. IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.
Ghigo E; Barry AO; Pretat L; Al Moussawi K; Desnues B; Capo C; Kornfeld H; Mege JL
PLoS One; 2010 Oct; 5(10):e13561. PubMed ID: 21042409
[TBL] [Abstract][Full Text] [Related]
69. [Whipple's disease, an example of interactions between gastrointestinal flora and the macroorganism?].
Knoke M; Möllmann R; Bernhardt H; Lorenz G; Königstedt B
Nahrung; 1987; 31(5-6):553-5, 644. PubMed ID: 2443850
[TBL] [Abstract][Full Text] [Related]
70. Is there an immune deficit in Whipple's disease?
Dobbins WO
Dig Dis Sci; 1981 Mar; 26(3):247-52. PubMed ID: 6165533
[TBL] [Abstract][Full Text] [Related]
71. Plasticity of T reg at infected sites.
Wohlfert E; Belkaid Y
Mucosal Immunol; 2010 May; 3(3):213-5. PubMed ID: 20237465
[TBL] [Abstract][Full Text] [Related]
72. Diagnostic Approach for Classic Compared With Localized Whipple Disease.
Crews NR; Cawcutt KA; Pritt BS; Patel R; Virk A
Open Forum Infect Dis; 2018 Jul; 5(7):ofy136. PubMed ID: 29992176
[TBL] [Abstract][Full Text] [Related]
73. Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution.
Xiong G; Yang L; Chen Y; Fan Z
Am J Transl Res; 2015; 7(11):2262-9. PubMed ID: 26807174
[TBL] [Abstract][Full Text] [Related]
74. Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses.
Höfer T; Krichevsky O; Altan-Bonnet G
Front Immunol; 2012; 3():268. PubMed ID: 22973270
[TBL] [Abstract][Full Text] [Related]
75. Cancer inflammation and regulatory T cells.
Erdman SE; Poutahidis T
Int J Cancer; 2010 Aug; 127(4):768-79. PubMed ID: 20518013
[TBL] [Abstract][Full Text] [Related]
76. Multiple examples of the blood genotype CwD-/CwD- in a Canadian family.
GUNSON HH; DONOHUE WL
Vox Sang; 1957 Oct; 2(5):320-31. PubMed ID: 13530898
[No Abstract] [Full Text] [Related]
77. Current knowledge of the immune reconstitution inflammatory syndrome in Whipple disease: a review.
Song X; Duan R; Duan L; Wei L
Front Immunol; 2023; 14():1265414. PubMed ID: 37901208
[TBL] [Abstract][Full Text] [Related]
78. Uptake of
Friebel J; Schinnerling K; Weigt K; Heldt C; Fromm A; Bojarski C; Siegmund B; Epple HJ; Kikhney J; Moter A; Schneider T; Schulzke JD; Moos V; Schumann M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047170
[TBL] [Abstract][Full Text] [Related]
79. Cytotoxic CD8
Friebel J; Witkowski M; Wegner M; Blöbaum L; Lammel S; Schencke PA; Jakobs K; Puccini M; Reißner D; Steffens D; Moos V; Schutheiss HP; Landmesser U; Rauch U
Cells; 2022 Dec; 12(1):. PubMed ID: 36611934
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
